Skip to main content
OpenTrials
Completed

NCT Number: NCT05968924

Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology

The investigator team will study the adherence of the participant cohort to a non significant risk device over a six month period. The device is a foot mat, which can detect changes in foot temperature that may predict foot ulceration in patients with diabetes mellitus. This mat, the Podimetrics Smart Mat, is FDA cleared.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Innovations toward the prevention of diabetic foot ulcer (DFU) are needed. Early detection of changes in the foot that predict the development of DFU could allow timely intervention to prevent the limb damage that occurs with advanced DFU.

Studies have demonstrated that increased temperature in the foot presage the development of DFU. Temperature changes can accurately be detected by home monitoring devices and predict impending ulceration. Here the study team will test the uptake of novel foot temperature monitoring technology for a future intervention study to determine if a home monitoring device could prevent the occurrence of severe DFU for patients at Montefiore Medical Center (MMC).

The investigator team will conduct a longitudinal study to determine the adherence to an FDA cleared device, Podimetrics, which has been tested in other populations and shown to 1) decrease the risk of severe DFU, and 2) decrease the utilization of health care resources in high risk patients with a history of DFU.

For this study, the study team will identify and enroll patients who are at high risk for DFU. These participants will be identified from the electronic medical record (EMR) and have case report form filled out.

After providing informed consent, study participants will receive the foot mat and obtain training remotely from Podimetrics, which provides a standardized training program.

Participants briefly stand on the mat daily (20 seconds), and the temperature data is automatically sent for analysis to Podimetrics to interpret the information. The participants will be evaluated over a six-month period to measure:

  • Daily use of the technology
  • Secondary outcomes: occurrence of DFU and use of health care resources.

Study participants will be contacted every month by the Einstein investigators to assess foot health. Study participants will be instructed to contact the study team during the study period to inquire if development of any changes in the foot such as the diagnosis of DFU, or if a foot cast is required for offloading, or if participants have any concerns about their feet.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type 1 or Type 2 diabetes mellitus
  • Prior treatment of DFU within 24 months
  • Subject had at least one outpatient follow up with a provider after treatment for DFU
  • No active ulcer at time of enrollment
  • Male or female, aged 18-75 yrs
  • Presence of Neuropathy
  • Ambulatory
  • Provision of signed and dated informed consent form
  • Stated willingness to adhere with all study procedures and availability to participate for the duration of the study

Exclusion criteria

  • Active diabetic foot ulcer (DFU)
  • Unable to comply with study requirements
  • Prior above-knee amputation (AKA) or below-knee amputation (BKA)

Treatment and study plan

Podimetrics SmartMat

Device

Participants receive training for stepping on SmartMat each day for 6 months. Monthly phone calls will be conducted to assess foot health and mat.

Primary outcomes

  1. Adherence to Use of SmartMat

    Time frame: Up to six months following intervention

    Participant adherence to use of SmartMat will be quantified by automated data collection. Adherence is defined as having conducted >3 days foot scans per week (foot scans/week) over the six-month period. The median number of scans/week over a six-month period is reported.

Secondary outcomes

  1. Use of Health Care Facilities

    Time frame: Up to six months following intervention

    Use of health care facilities will be enumerated based on the number of participants who presented for care over the course of the study. This will include patient visits to the Emergency Room (ER), podiatrist, internist, walk in clinic, and other health care facilities. This outcome will be based on participant self-reporting of visits. The total number of participants who visited a health care facility is summarized.

  2. Occurrence of Diabetic Foot Ulcer (DFU)

    Time frame: Up to six months following intervention

    The number of participants who developed DFU during the course of the study is summarized. Diagnosis of DFU was be based on a physical exam.

Sponsors and collaborators

Lead sponsor

Montefiore Medical Center

Other

Collaborators

  • American Diabetes Association
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Podimetrics, Inc.

Registry information

Acronym: DFUMAT

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 1, 2023
Registry last updated
Apr 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.